WKL has ~85% recurring revenue, 29.4% margins, 5% organic growth, recurring revenue up 7%, FCF up 14%, and ongoing share cancellations. Trading at 15-16x forward earnings vs peers in mid-20s, while AI fears have derated the stock despite accelerating fundamentals. Market is pricing in permanent growth impairment not reflected in customer behavior, renewals, or AI adoption. AI disruption remains unresolved; slower organic growth could make the stock dead money; rising R&D spend may not convert to adoption.
WKL has ~85% recurring revenue, 29.4% margins, 5% organic growth, recurring revenue up 7%, FCF up 14%, and ongoing share cancellations. Trading at 15-16x forward earnings vs peers in mid-20s, while AI fears have derated the stock despite accelerating fundamentals. Market is pricing in permanent growth impairment not reflected in customer behavior, renewals, or AI adoption. AI disruption remains unresolved; slower organic growth could make the stock dead money; rising R&D spend may not convert to adoption.